Global T Cell Specific Surface Glycoprotein CD28 Market Research Report 2017

REPORT ID 393

Global T Cell Specific Surface Glycoprotein CD28 Market Research Report 2017

Publish Date

01-Dec-17

Pages

108

Format

Electronic (PDF)

Full report description

In this report, the global T Cell Specific Surface Glycoprotein CD28 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of T Cell Specific Surface Glycoprotein CD28 in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global T Cell Specific Surface Glycoprotein CD28 market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Atox Bio Ltd
    Bristol-Myers Squibb Co
    Five Prime Therapeutics Inc
    Johnson & Johnson
    TheraMAB LLC
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    FPT-155
    FR-104
    Lulizumab Pegol
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Plaque Psoriasis
    Solid Tumor
    Acute Renal Failure(ARF)
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

Global T Cell Specific Surface Glycoprotein CD28 Market Research Report 2017
1 T Cell Specific Surface Glycoprotein CD28 Market Overview
    1.1 Product Overview and Scope of T Cell Specific Surface Glycoprotein CD28
    1.2 T Cell Specific Surface Glycoprotein CD28 Segment by Type (Product Category)
        1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global T Cell Specific Surface Glycoprotein CD28 Production Market Share by Type (Product Category) in 2016
        1.2.3 FPT-155
        1.2.4 FR-104
        1.2.5 Lulizumab Pegol
        1.2.6 Others
    1.3 Global T Cell Specific Surface Glycoprotein CD28 Segment by Application
        1.3.1 T Cell Specific Surface Glycoprotein CD28 Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Plaque Psoriasis
        1.3.3 Solid Tumor
        1.3.4 Acute Renal Failure(ARF)
        1.3.5 Others
    1.4 Global T Cell Specific Surface Glycoprotein CD28 Market by Region (2012-2022)
        1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of T Cell Specific Surface Glycoprotein CD28 (2012-2022)
        1.5.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue Status and Outlook (2012-2022)
        1.5.2 Global T Cell Specific Surface Glycoprotein CD28 Capacity, Production Status and Outlook (2012-2022)

2 Global T Cell Specific Surface Glycoprotein CD28 Market Competition by Manufacturers
    2.1 Global T Cell Specific Surface Glycoprotein CD28 Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global T Cell Specific Surface Glycoprotein CD28 Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global T Cell Specific Surface Glycoprotein CD28 Production and Share by Manufacturers (2012-2017)
    2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Share by Manufacturers (2012-2017)
    2.3 Global T Cell Specific Surface Glycoprotein CD28 Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers T Cell Specific Surface Glycoprotein CD28 Manufacturing Base Distribution, Sales Area and Product Type
    2.5 T Cell Specific Surface Glycoprotein CD28 Market Competitive Situation and Trends
        2.5.1 T Cell Specific Surface Glycoprotein CD28 Market Concentration Rate
        2.5.2 T Cell Specific Surface Glycoprotein CD28 Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global T Cell Specific Surface Glycoprotein CD28 Capacity and Market Share by Region (2012-2017)
    3.2 Global T Cell Specific Surface Glycoprotein CD28 Production and Market Share by Region (2012-2017)
    3.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global T Cell Specific Surface Glycoprotein CD28 Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption by Region (2012-2017)
    4.2 North America T Cell Specific Surface Glycoprotein CD28 Production, Consumption, Export, Import (2012-2017)
    4.3 Europe T Cell Specific Surface Glycoprotein CD28 Production, Consumption, Export, Import (2012-2017)
    4.4 China T Cell Specific Surface Glycoprotein CD28 Production, Consumption, Export, Import (2012-2017)
    4.5 Japan T Cell Specific Surface Glycoprotein CD28 Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production, Consumption, Export, Import (2012-2017)
    4.7 India T Cell Specific Surface Glycoprotein CD28 Production, Consumption, Export, Import (2012-2017)

5 Global T Cell Specific Surface Glycoprotein CD28 Production, Revenue (Value), Price Trend by Type
    5.1 Global T Cell Specific Surface Glycoprotein CD28 Production and Market Share by Type (2012-2017)
    5.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Type (2012-2017)
    5.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2012-2017)
    5.4 Global T Cell Specific Surface Glycoprotein CD28 Production Growth by Type (2012-2017)

6 Global T Cell Specific Surface Glycoprotein CD28 Market Analysis by Application
    6.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption and Market Share by Application (2012-2017)
    6.2 Global T Cell Specific Surface Glycoprotein CD28 Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Profiles/Analysis
    7.1 Atox Bio Ltd
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bristol-Myers Squibb Co
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Five Prime Therapeutics Inc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Johnson & Johnson
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 TheraMAB LLC
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    ...

8 T Cell Specific Surface Glycoprotein CD28 Manufacturing Cost Analysis
    8.1 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 T Cell Specific Surface Glycoprotein CD28 Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of T Cell Specific Surface Glycoprotein CD28 Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global T Cell Specific Surface Glycoprotein CD28 Market Forecast (2017-2022)
    12.1 Global T Cell Specific Surface Glycoprotein CD28 Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global T Cell Specific Surface Glycoprotein CD28 Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global T Cell Specific Surface Glycoprotein CD28 Price and Trend Forecast (2017-2022)
    12.2 Global T Cell Specific Surface Glycoprotein CD28 Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global T Cell Specific Surface Glycoprotein CD28 Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global T Cell Specific Surface Glycoprotein CD28 Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer